Conclusions: The prevalence of sleep apnoea among patients following treatment of head and neck carcinomas seems to be slightly higher than in the normal population. The possible importance of tumour treatment features, especially transient tracheostoma, needs further assessment.
Objectives: The epidemiology of sleep apnoea in patients following the treatment of head and neck cancer remains unclear. This study was undertaken to assess the prevalence of sleep apnoea in head and neck cancer patients by characterizing their clinical, anatomical and tumour treatment features.
Patients And Methods: Our study examined 31 patients in a prospective non-controlled study using a standardized questionnaire that included the Epworth Sleepiness Scale (ESS) and a polygraph.
Results: Six of the 31 patients showed a pathologic AHI > or = 20/h. Subjects positive for sleep apnoea more often had a tumour of the hypopharynx or larynx and more often had a transient tracheostoma during cancer therapy. Radiotherapy had no clear impact on the prevalence of sleep apnoea.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/00016480802613113 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure.
Int Clin Psychopharmacol
January 2025
Department of Medicine, University of California, San Francisco - Fresno, Fresno, California, USA.
Obstructive sleep apnea (OSA) is a prevalent sleep disorder linked to significant daytime sleepiness and mood disturbances. Continuous positive airway pressure (CPAP) therapy is the standard treatment for OSA, but its effects on mental health outcomes, are not well understood. This study aimed to evaluate the impact of CPAP on daytime sleepiness, depressive symptoms, and anxiety symptoms while assessing how improvements vary with age.
View Article and Find Full Text PDFCentral Sleep Apnea and Cardiovascular Disease State-of-the-Art.
Sleep
December 2024
Midwest Cardiovascular Institute, Naperville, Illinois, USA.
Central sleep apnea (CSA), a rare polysomnographic finding in the general population, is prevalent in certain cardiovascular conditions including systolic and diastolic left ventricular dysfunction, atrial fibrillation, coronary artery disease, carotid artery stenosis, stroke and use of certain cardiac-related medications. Polysomnographic findings of CSA with adverse cardiovascular impacts include nocturnal hypoxemia and arousals, which can lead to increased sympathetic activity both at night and in the daytime. Among cardiovascular diseases, CSA is most prevalent in patients with left ventricular systolic dysfunction; a large study of more than 900 treated patients has shown a dose dependent relationship between nocturnal desaturation and mortality.
View Article and Find Full Text PDFBackground: Obstructive sleep apnea (OSA) is a complex and heterogeneous condition associated with chronic physiological and neuropsychological disturbances (1-4). One notable neuropsychological effect observed in OSA patients is memory impairment (2,5). Additionally, some reports suggest that OSA may be associated with Alzheimer's Disease (AD) (4).
View Article and Find Full Text PDFBiomarkers.
Alzheimers Dement
December 2024
Ageing Epidemiology Reseach Unit (AGE), School of Public Health, Imperial College London, London, UK.
Background: Several studies have investigated the link between sleep disturbances and allostatic load (AL), but the results are varied, and less is known about the associations in clinical samples. The goal of this study is to assess the associations between sleep disturbances and AL among memory clinic participants, and to examine differences according to sex, beta-amyloid status and history of burnout status.
Method: The study was based on 146 memory clinic participants diagnosed with either Mild Cognitive Impairment (MCI) or Subjective Cognitive Impairment (SCI) in the Cortisol and Stress in Alzheimer's Disease Study (Co-STAR) (Sweden).
Biomarkers.
Alzheimers Dement
December 2024
Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, USA.
Background: Aging is associated with disruptions in non-rapid eye movement (NREM) sleep and memory decline. Cerebral small vessel disease (CSVD) increases with age and is associated with clinical sleep disturbance, but little is known about its relationship with local expression of NREM sleep. Here, we explore associations between CSVD burden, memory, and local electroencephalography (EEG) measures during NREM sleep in older adults.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!